Clinical trial Recruiting at 1 site Interventional Ages Any age to 17

Able Kids device: safer gait aid for kids with neurologic gait problems

Official title: Clinical Investigation to Validate the Safety and Performance of the ABLE Kids Device in Pediatric Patients With Neurological Gait Disorders in a Clinical Setting

Run by ABLE Human Motion S.L. · NCT07745712 · Data updated 2026-11-12

This study tests whether the ABLE Kids wearable exoskeleton can be safely used during a 10-session gait training program for children with neurological gait disorders or muscle weakness.

Quick facts

Study typeInterventional
AgesAny age to 17 Years
SexAll
Enrollment15 (estimated)
SponsorABLE Human Motion S.L.
Industry-sponsored
Locations1 site (Girona, Girona)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 8, 2026
Trial IDNCT07745712 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents with gait impairments due to neurological conditions or muscular weakness, who meet anthropometric and clinical criteria and have guardian consent.

Probably not a fit

Patients who do not benefit may include those who do not tolerate the device, do not meet all inclusion criteria, or experience adverse events limiting use.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, pre-post study evaluating safety and clinical performance of the ABLE Kids device in pediatric patients with gait impairments due to neurological conditions or muscular weakness. Participants undergo baseline assessment, followed by a 10-session, 60-minute per session gait training program over up to three weeks, with data collected on safety and device performance. A post-training assessment occurs within one week after training, and a follow-up call two weeks later to capture any adverse events. The study aims to gather preliminary data on potential clinical and psychosocial benefits, while ensuring eligibility through specific anthropometric and clinical criteria. Recruitment targets at least 10 evaluable participants within about 11 weeks at a single center in Girona, Spain.

Why it matters

Potential benefit: If successful, the device could improve gait training outcomes and quality of life for pediatric patients with gait disorders.

How similar studies have gone: Previous work with similar wearable exoskeletons in pediatric populations has shown safety signals and potential functional benefits, but data are limited and each device requires separate validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Minors with gait impairments, ranging from mild to severe, resulting from neurological conditions or muscular weakness
* Anthropometric measurements compatible with the use of the exoskeleton, particularly:
* Weight under 75 kg
* Height between 1.0-1.5 m
* Hip: maximum distance between greater trochanters of 35 cm
* Thigh: maximum distance from trochanter to knee joint line of 36 cm
* Lower leg: maximum distance from knee joint line to shoe sole of 45 cm
* Medically stable
* Intact skin in areas in contact with the device
* Favorable medical assessment for standing, gait training, and weight-bearing activities
* Signed informed consent from parents or legal guardians, and assent from the minor whenever possible, according to age and cognitive ability

Exclusion Criteria:

* Severe spasticity in the lower limbs (Modified Ashworth Scale \[MAS\] \> 3)
* Severe osteoporosis resulting in atraumatic bone fractures
* Unhealed fractures or history of fragility fractures in the lower extremities within the past 2 years
* Unstable or painful hip dislocation (Migration Percentage \[MP\] \> 50%)
* Symptomatic heterotopic ossification with mechanical limitation or pain
* Anatomical limitations incompatible with proper fitting and safe use of the device:
* Leg length discrepancy \>1.5 cm in the upper segment or \>2.0 cm in the lower segment
* Severe scoliosis (Cobb angle \>40° without the possibility of orthotic use during operation)
* Inability to achieve proper adjustment within the device
* Joint range of motion limitations preventing use of the exoskeleton:
* Knee flexion contracture ≥40°
* Hip flexion contracture ≥20°
* Rigid equinus foot
* Spine or lower extremity surgery within the last 3 months
* Recently implanted pacemakers
* Inability to communicate pain, fear, or discomfort (verbally or nonverbally)
* Daytime mechanical ventilation
* Uncontrolled epileptic seizures
* Medical or cardiovascular instability
* Considered unsuitable by physicians and physiotherapists. Any acute medical condition such as fever, infection, respiratory problems, urinary symptoms, uncontrolled pain, new swelling or redness in the extremities, active deep vein thrombosis, or severe comorbidities considered incompatible with the use of ABLE Kids until clinical resolution
* Absence of head or trunk control in sitting or standing that cannot be compensated through the use of orthotic support during exoskeleton use

Where it's running

  • Som·hi Rehab
    Girona, Girona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Use of invasive home ventilation in Denmark

    This project will see how often people with neuromuscular diseases or spinal cord injuries in Denmark used invasive home mechanical ventilation between 2016 and 2025 and what their one-year outcomes were.

    Recruiting Copenhagen University Hospital, Rigshospitalet · Copenhagen · NCT07467187

  • Monitoring daily fatigue in adults with cerebral palsy or acquired brain injury

    This project will try to capture how often and how intense fatigue is for adults with cerebral palsy or acquired brain injury by asking them to report symptoms on their phone multiple times a day.

    Recruiting Copenhagen University Hospital, Rigshospitalet · Glostrup Municipality · NCT07135791

  • Using brain-computer interface technology to improve walking in spinal cord injury patients

    This study is testing a new brain-computer interface system to see if it can help people with spinal cord injuries walk better and improve their quality of life.

    Recruiting Xuanwu Hospital, Beijing · Beijing, Beijing Municipality · NCT06939660

  • Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work

    This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.

    Recruiting at 2 sites Karolinska Institutet · Luleå, Norrbotten County and 2 other locations · NCT07924774

  • Manual Therapy Before Neuromotor Rehab in Children with Cerebral Palsy

    In this pilot study, researchers test whether 30 minutes of lower-limb manual therapy before functional neuromotor therapy helps improve gait and motor performance in children with spastic cerebral palsy.

    Recruiting LIFE - Research and Care Institute - Santa Lucia IRCCS · Roma, Roma · NCT07902466

  • Rehabilitation data registry for spinal cord injury in Korea

    This study tests whether long‑term disability and function after spinal cord injury can be predicted by combining medical and socioeconomic information gathered during and after inpatient rehabilitation.

    Recruiting Seoul National University Hospital · Yangpyeong, Gyeonggi-do · NCT07901985

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.